B. Kumar, S. Kumari, Neelam Khandelwal, D. Kumar, S. Dhaked, R. Bhatt
{"title":"Obesity: An important predictor of metabolic syndrome","authors":"B. Kumar, S. Kumari, Neelam Khandelwal, D. Kumar, S. Dhaked, R. Bhatt","doi":"10.5937/scriptamed54-40389","DOIUrl":null,"url":null,"abstract":"Background/Aim: The leading avoidable cause of mortality in the world is obesity. It modifies how the body reacts to insulin, which might result in insulin resistance and an elevated risk of type 2 diabetes. Recent investigations have revealed a link between obesity and the metabolic syndrome. Therefore, it was intended for the current study to look at the prevalence of obesity and how it relates to the metabolic syndrome. Methods: 120 healthy males between 30-50 years of age were chosen from the general population of Kota District, Rajasthan, India and screened for obesity and divided in three groups: normal, overweight and obese. Each group comprised of forty subject. Serum was separated and run in department of biochemistry , GMC Kota. Anthropometric parameters were taken. The completely automated analyser ERBA EM 360 performed lipid profile and blood sugar analyses on serum. Result: Obesity increased metabolic syndrome prevalence. In comparison to overweight and normal weight people, obese subjects exhibited considerably lower levels of high-density lipoprotein (HDL) cholesterol and significantly higher levels of blood glucose, triglycerides, total cholesterol and low-density lipoprotein (LDL) cholesterol. Additional coronary artery disease (CAD) risk prediction ratios, such as total cholesterol/HDL, LDL/HDL and triglycerides/ HDL ratios that have gradually increased from the normal to obese group, show that obese subjects have a relatively higher risk of developing cardiovascular diseases (CVD) than do those in the overweight and normal groups. Conclusion: One of the key elements of metabolic syndrome, which is a collection of clinical and metabolic anomalies including abdominal obesity, insulin resistance, hypertension and dyslipidaemia, is obesity. Each of these conditions raises the risk of CVD and diabetes mellitus type 2 directly. The progression towards diabetes and CVD can be prevented by lifestyle modification programmes and regular health checks (to explore the risk factors of metabolic syndrome).","PeriodicalId":33497,"journal":{"name":"Scripta Medica","volume":"49 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Scripta Medica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5937/scriptamed54-40389","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Background/Aim: The leading avoidable cause of mortality in the world is obesity. It modifies how the body reacts to insulin, which might result in insulin resistance and an elevated risk of type 2 diabetes. Recent investigations have revealed a link between obesity and the metabolic syndrome. Therefore, it was intended for the current study to look at the prevalence of obesity and how it relates to the metabolic syndrome. Methods: 120 healthy males between 30-50 years of age were chosen from the general population of Kota District, Rajasthan, India and screened for obesity and divided in three groups: normal, overweight and obese. Each group comprised of forty subject. Serum was separated and run in department of biochemistry , GMC Kota. Anthropometric parameters were taken. The completely automated analyser ERBA EM 360 performed lipid profile and blood sugar analyses on serum. Result: Obesity increased metabolic syndrome prevalence. In comparison to overweight and normal weight people, obese subjects exhibited considerably lower levels of high-density lipoprotein (HDL) cholesterol and significantly higher levels of blood glucose, triglycerides, total cholesterol and low-density lipoprotein (LDL) cholesterol. Additional coronary artery disease (CAD) risk prediction ratios, such as total cholesterol/HDL, LDL/HDL and triglycerides/ HDL ratios that have gradually increased from the normal to obese group, show that obese subjects have a relatively higher risk of developing cardiovascular diseases (CVD) than do those in the overweight and normal groups. Conclusion: One of the key elements of metabolic syndrome, which is a collection of clinical and metabolic anomalies including abdominal obesity, insulin resistance, hypertension and dyslipidaemia, is obesity. Each of these conditions raises the risk of CVD and diabetes mellitus type 2 directly. The progression towards diabetes and CVD can be prevented by lifestyle modification programmes and regular health checks (to explore the risk factors of metabolic syndrome).
背景/目的:世界上可避免的主要死亡原因是肥胖。它改变了身体对胰岛素的反应,这可能导致胰岛素抵抗和患2型糖尿病的风险增加。最近的调查揭示了肥胖和代谢综合症之间的联系。因此,目前的研究旨在研究肥胖的患病率及其与代谢综合征的关系。方法:选取印度拉贾斯坦邦哥打县普通人群中30 ~ 50岁的健康男性120例,进行肥胖筛查,分为正常组、超重组和肥胖组。每组由40名受试者组成。血清分离并在哥大GMC生物化学系运行。测量人体测量参数。全自动分析仪ERBA EM 360对血清进行血脂和血糖分析。结果:肥胖增加代谢综合征患病率。与超重和正常体重的人相比,肥胖受试者的高密度脂蛋白(HDL)胆固醇水平明显较低,血糖、甘油三酯、总胆固醇和低密度脂蛋白(LDL)胆固醇水平明显较高。其他冠心病(CAD)风险预测比率,如总胆固醇/高密度脂蛋白、低密度脂蛋白/高密度脂蛋白和甘油三酯/高密度脂蛋白比率,从正常到肥胖组逐渐增加,表明肥胖受试者发生心血管疾病(CVD)的风险相对高于超重和正常组。结论:代谢综合征是腹部肥胖、胰岛素抵抗、高血压、血脂异常等临床和代谢异常的集合,肥胖是代谢综合征的关键因素之一。这些情况都会直接增加心血管疾病和2型糖尿病的风险。糖尿病和心血管疾病的发展可以通过改变生活方式和定期健康检查来预防(以探索代谢综合征的危险因素)。